Industry advises FDA not to issue more guidances without public comment
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesRegulatory NewsMary Ellen SchneiderBiologics/ biosimilars/ vaccinesMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited States